Cawley D B, Simpson D L, Herschman H R
Proc Natl Acad Sci U S A. 1981 Jun;78(6):3383-7. doi: 10.1073/pnas.78.6.3383.
We have constructed a toxic hybrid protein that is recognized by asialoglycoprotein (ASGP) receptors of cultured rat hepatocytes. The conjugate consists of fragment A of diphtheria toxin (DTA) linked by a disulfide bond to asialofetuin (ASF). This conjugate is highly toxic, inhibiting protein synthesis in primary rat hepatocytes at concentrations as low as 10 pM. The ASF-DTA conjugate was 600 and 1800 times as toxic as diphtheria toxin and DTA, respectively, on primary rat hepatocytes. The ASGP receptor recognizes galactose-terminated proteins. We tested a series of glycoproteins for their ability to block the action of the ASF-DTA conjugate. Fetuin and orosomucoid, two glycoproteins with terminal sialic acid on their oligosaccharide chains, did not block the action of the conjugate. Their galactose-terminated asialo derivatives, ASF and asialoorosomucoid, as expected, did block the action of the conjugate. The N-acetylglucosaminyl-terminated derivative (asialogalactoorsomucoid) had no appreciable effect on the activity of the conjugate. We tested the ASF-DTA conjugate on six cell types; except for primary rat hepatocytes, none of them were affected by a high concentration (10 nM) of ASF-DTA conjugate. A fetuin-DTA conjugate was less toxic by a factor of 300 than the ASF-DTA conjugate and exerted its effects primarily through non-receptor-mediated mechanisms. The highly toxic ASF-DTA conjugate is cell-type specific, and its action is mediated by a well-characterized receptor, whose mechanism of receptor-ligand internalization has been extensively investigated.
我们构建了一种毒性杂合蛋白,该蛋白可被培养的大鼠肝细胞的去唾液酸糖蛋白(ASGP)受体识别。该偶联物由白喉毒素(DTA)的A片段通过二硫键与去唾液酸胎球蛋白(ASF)相连组成。这种偶联物毒性很强,在低至10 pM的浓度下就能抑制原代大鼠肝细胞中的蛋白质合成。ASF-DTA偶联物对原代大鼠肝细胞的毒性分别是白喉毒素和DTA的600倍和1800倍。ASGP受体识别半乳糖末端的蛋白质。我们测试了一系列糖蛋白阻断ASF-DTA偶联物作用的能力。胎球蛋白和血清类黏蛋白这两种在其寡糖链上带有末端唾液酸的糖蛋白,不能阻断偶联物的作用。正如预期的那样,它们的半乳糖末端去唾液酸衍生物ASF和去唾液酸血清类黏蛋白确实能阻断偶联物的作用。N-乙酰葡糖胺末端衍生物(去唾液酸半乳糖血清类黏蛋白)对偶联物的活性没有明显影响。我们在六种细胞类型上测试了ASF-DTA偶联物;除了原代大鼠肝细胞外,它们中没有一种受到高浓度(10 nM)ASF-DTA偶联物的影响。胎球蛋白-DTA偶联物的毒性比ASF-DTA偶联物低300倍,其作用主要通过非受体介导的机制发挥。高毒性的ASF-DTA偶联物具有细胞类型特异性,其作用由一种特征明确的受体介导,该受体-配体内化机制已得到广泛研究。